Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | RECQL | P46063 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 1/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.61 |
| ▸ | CASP1 | P29466 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | NT5E | P21589 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | SNCA | P37840 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9175160 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL18270518 | 0.94 | ALDH1A1 (0.55) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL18507794 | 0.88 | CA12 (0.69) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| Sulfuric Acid SCHEMBL16207785 | 0.85 | ALDH1A1 (0.81) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL18270522 | 0.84 | TIMP3 (0.60) | ALDH1A1CA12CA2HSD17B10CA1 | |
| SCHEMBL14447648 | 0.82 | APP (0.60) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL11715148 | 0.82 | LMNA (0.48) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL5561256 | 0.81 | SNCA (0.65) | ALDH1A1CA12CA2RECQLHSD17B10 | |
| SCHEMBL9154737 | 0.80 | SNCA (0.60) | ALDH1A1CA12CA2CA1LMNA | |
| SCHEMBL8848749 | 0.80 | LMNA (0.56) | ALDH1A1CA2HSD17B10CA1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112881311-B | Creatine kinase detection reagent, kit and detection method | 深圳迈瑞生物医疗电子股份有限公司 | 2025-05-30 | — | — | CN | claimed |
| CN-119118882-A | Olatinib intermediate and preparation method thereof and preparation method of Olatinib | 浙江荣耀生物科技股份有限公司 | 2024-12-13 | — | — | CN | claimed |
| US-11807774-B2 | Thoroughly modified, functionalized polymeric hard coating material for coatings, methods for synthesizing the same and applications thereof | NANO AND ADVANCED MATERIALS INSTITUTE LIMITED (HK) | 2023-11-07 | — | — | US | claimed |
| US-20230159484-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | DYOMICS GMBH (DE) | 2023-05-25 | — | — | US | claimed |
| EP-4127069-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | Dyomics GmbH (DE) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198433-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | DYOMICS GMBH (DE) | 2021-10-07 | — | — | WO | claimed |
| CN-112881311-A | Creatine kinase detection reagent, kit and detection method | 深圳迈瑞生物医疗电子股份有限公司 | 2021-06-01 | — | — | CN | claimed |
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| EP-1266068-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | Novozymes North America, Inc. (US) | 2002-12-18 | — | — | EP | claimed |
| WO-2001044563-A1 | ENZYMATIC METHOD FOR TEXTILE DYEING | NOVOZYMES NORTH AMERICA, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| EP-0333656-A1 | Reactive dyes, process for their preparation and their use | CIBA-GEIGY AG (CH) | 1989-09-20 | — | — | EP | claimed |
| US-4138558-A | Anthraquinone compounds | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1979-02-06 | — | — | US | claimed |
| CN-122029970-A | Photoelectric conversion element and solar cell module | 株式会社安能科多科技 | 2026-05-12 | — | — | CN | disclosed |
| EP-4190832-B1 | POLYISOCYANATE COMPOSITION, COATING COMPOSITION AND COATED SUBSTRATE | ASAHI CHEMICAL IND (JP) | 2026-04-08 | — | — | EP | disclosed |
| CN-116903850-B | Ionic polymer electrolyte LiPSBI and preparation method and application thereof | 山东正熵能源科技有限公司 | 2026-01-30 | — | — | CN | disclosed |
| US-20250386657-A1 | PHOTOELECTRIC CONVERSION ELEMENT | ENECOAT TECH CO LTD (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-0013879-B1 | REACTIVE DYESTUFFS, THEIR PREPARATION AND THEIR USE FOR DYEING MATERIALS CONTAINING HYDROXYL OR AMIDE GROUPS | BAYER AG (DE) | 1982-09-15 | — | — | EP | disclosed |
| EP-0013879-A1 | Reactive dyestuffs, their preparation and their use for dyeing materials containing hydroxyl or amide groups | BAYER AG (DE) | 1980-08-06 | — | — | EP | disclosed |
| US-4138558-A | Anthraquinone compounds | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4028357-A | COLOR PRECURSORS | STERLING DRUG INC. (US) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159484-A1 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | SUN2, IK, BRD7 | ALDH1A1 1390/4885CA12 853/4885CA2 144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.